Mark Beaudet, Chairman of ILKOS THERAPEUTIC, is pleased to announce the appointment of Monique Champagne as President and Chief Executive Officer of the Laval biotech firm.
Monique Champagne brings to the company 29 years of experience in clinical research, drug development and regulatory affairs, acquired in the pharmaceutical, biotechnology and contract industries. A creative manager, she has extensive practical experience and expertise in the first phases of oncology drug development, in clinical development in various therapeutic areas, clinic operations management, regulatory affairs, integration and improvement of operational processes, as well as in managing international projects and professional relations with business partners.